UNSPSC 51385101: Amixetrine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7UL287YTPJ, chemically known as pyrrolidine, n-(2-phenyl-2-isoamyloxy)ethyl- but generally known as amixetrine, which bears US NIH Compound Identifier 71911. Amixetrine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amixetrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05464MIG.

UNSPSC 51385101 Amixetrine, a Commodity code, shows limited recent state and local procurement activity. The single identified opportunity involves pharmaceutical and public-health products—specifically naloxone and drug-deactivation systems—rather than amixetrine itself, suggesting the code may be misapplied to this solicitation or the purchasing database reflects a classification mismatch between the code and the actual goods being acquired.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023. The contract includes a two-year initial term with one-year renewal option, fixed-fee pricing, drug-free workplace and E-Verify compliance requirements, and standard insurance coverage mandates. The procurement notes potential FEMA funding and associated federal compliance obligations. Beyond this single opportunity, the code shows no additional recent state and local activity in the source material. Given the mismatch between the nominal code scope and the naloxone-focused work actually being solicited, this code warrants close monitoring for clarification of whether amixetrine-specific demand exists among state and local buyers or whether the classification reflects data-quality issues in the purchasing system.